Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5334)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2021 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Seen TK, Sayed M, Bilal M, Reyes JV, Bhandari P, Lourdusamy V, Al-khazraji A, Syed U, Sattar Y, Bansal R. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. World J Gastroenterol 2021; 27(23): 3238-3248 [PMID: 34163108 DOI: 10.3748/wjg.v27.i23.3238] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i23/3238.htm |
| Number | Citing Articles |
| 1 |
Anna Juliane Vesting, Alexander Jais, Paul Klemm, Lukas Steuernagel, Peter Wienand, Morten Fog-Tonnesen, Henning Hvid, Anna–Lena Schumacher, Christian Kukat, Hendrik Nolte, Theodoros Georgomanolis, Janine Altmüller, Manolis Pasparakis, Andreas Schmidt, Marcus Krüger, Marc Schmidt Supprian, Ari Waisman, Beate Katharina Straub, Nathanael Raschzok, Michel Bernier, Andreas L. Birkenfeld, Nadine Hövelmeyer, Jens C. Brüning, F. Thomas Wunderlich. NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibition. Molecular Metabolism 2022; 66: 101626 doi: 10.1016/j.molmet.2022.101626
|
| 2 |
Xiyue Shen, Kai Luo, Juntao Yuan, Junling Gao, Bingqing Cui, Zhuoran Yu, Zhongbing Lu. Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression. Acta Pharmaceutica Sinica B 2023; 13(8): 3352 doi: 10.1016/j.apsb.2023.05.020
|
| 3 |
Christoffer A. Hagemann, Christian Legart, Mathias B. Møllerhøj, Martin R. Madsen, Henrik H. Hansen, Merete J. Kønig, Frederik Helgstrand, Flemming P. Hjørne, Anders Toxværd, Jill L. Langhoff, Urd L. Kielgast, Lise L. Gluud, Helene Ægidius, Kristoffer T. G. Rigbolt, Tina Vilsbøll, Jacob Jelsing, Filip K. Knop, Pavel Strnad. A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity. PLOS ONE 2022; 17(10): e0275901 doi: 10.1371/journal.pone.0275901
|
| 4 |
Valéria Sutti Nunes, Guilherme da Silva Ferreira, Eder Carlos Rocha Quintão. Cholesterol metabolism in aging simultaneously altered in liver and nervous system. Aging 2022; 14(3): 1549 doi: 10.18632/aging.203880
|
| 5 |
Sevtap Kılınç, Pelin Şahin, Zeynep Yığman, Ayşe Meltem Sevgili. Topiramate’s effects on normal and fatty liver. Drug and Chemical Toxicology 2023; : 1 doi: 10.1080/01480545.2023.2276083
|
| 6 |
Akiko Eguchi, Motoh Iwasa, Minori Yamada, Yasuyuki Tamai, Ryuta Shigefuku, Hiroshi Hasegawa, Yoshifumi Hirokawa, Akinobu Hayashi, Koji Okuno, Yuki Matsushita, Takuma Nakatsuka, Kenichiro Enooku, Koji Sakaguchi, Yoshinao Kobayashi, Tetsuji Yamaguchi, Masatoshi Watanabe, Yoshiyuki Takei, Hayato Nakagawa. A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis. Hepatology Communications 2022; 6(8): 1987 doi: 10.1002/hep4.1971
|